https://www.europharmajobs.com/job_display/289540/Senior_Medical_Science_Liaison_Solid_Tumours_BeOne_Medicines_Remote_United_Kingdom
Senior Medical Science Liaison, Solid Tumours - BeOne Medicines, Remote
Apply for the Senior Medical Science Liaison, Solid Tumours Job, BeOne Medicines, Remote, United Kingdom. Pharma Jobs in Europe from EuroPharmaJobs.com
medical science liaisonsolid tumoursbeone medicinesseniorremote
https://tickeron.com/symbol/ONC/
Who owns BeOne Medicines? ONC symbol Ownership - Tickeron.com
Who owns BeOne Medicines? Discover who is the most significant shareholders of BeOne Medicines are and learn how they control a substantial portion of the...
who ownsbeone medicinesoncsymbolownership
https://marketinference.com/analysis/r/2026/02/26/ONC/
BeOne Medicines Reports $5.3B Revenue in 2025 - Market Inference
BeOne Medicines Reports $5.3B Revenue in 2025
beone medicinesreportsrevenuemarketinference
https://palpalnewshub.com/beone-medicines-highlights-global-oncology-leadership-at-44th-annual-j-p-morgan-healthcare-conference/?amp
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare...
Jan 13, 2026 - BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will outline the pillars of its growing global oncology leadership...
j p morganbeone medicinesglobal oncologyhighlightsleadership
https://www.legal.io/jobs/5816540/Full-time/Contract-Manager-Clinical-Site-Contracts/Remote
Contract Manager, Clinical Site Contracts at BeOne Medicines | (Full Time) | Legal.io
Find work as a Contract Manager, Clinical Site Contracts and browse other temporary and permanent legal roles on Legal.io
contract managerbeone medicinesfull timeclinicalsite
https://d309lionsconvention.lionsclubs.org.sg/apply/job/director-training-and-knowledge-management-at-beone-medicines-emeryville-ca-dk1jZTByUkxpR091ZW1QUHlXZ201ODBCdGc9PQ==
Director, Training and Knowledge Management job at BeOne Medicines Emeryville, CA, US -...
Director, Training and Knowledge Management job at BeOne Medicines Emeryville, CA, US **General Description:** The Director, Training and Knowledge Management...
training and knowledgebeone medicinesemeryville cadirectormanagement
https://www.wallstreetzen.com/stocks/us/nasdaq/onc/ownership
Beone Medicines Stock Ownership - Who Owns Beone Medicines in 2026? | WallStreetZen
beone medicinesstock ownershipwho owns
https://ro.bulios.com/ticker/ONC
BeOne Medicines Ltd. (ONC) Stock | ONC Stock Price & Analysis - Bulios
Get the latest news and market analysis for BeOne Medicines Ltd. (ONC). Stay up-to-date on ONC Stock price and share price with Bulios. Explore our ONC Stock...
beone medicinesstock priceltdoncanalysis
https://www.lobbyregister.bundestag.de/suche/R004382/58802?backUrl=%2Fsuche%3Fq%3D%252220%252F11561%2522%26searchAttributes%3Ddraftbillprintingnumbers%252Cdraftbills%26pageSize%3D25%26sort%3DNAME_ASC
Registereintrag "BeOne Medicines Germany " - Lobbyregister beim Deutschen Bundestag
Sonstiges Unternehmen, eingetragen seit 29.04.2022, aktualisiert am 07.07.2025.
beim deutschen bundestagbeone medicinesregistereintraggermanylobbyregister
https://medicalupdateonline.com/tag/beone-medicines/
BeOne Medicines Archives - Medical Update Online
beone medicinesmedical updatearchivesonline
https://www.barchart.com/stocks/quotes/ONC
ONC - Beone Medicines Ltd Stock Price - Barchart.com
Beone Medicines Ltd stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
beone medicinesstock priceoncltdbarchart
https://www.sahmcapital.com/news/content/fda-grants-priority-review-to-beone-medicines-supplemental-biologics-license-application-for-tevimbra-tislelizumab-in-combination-with-ziihera-zanidatamab-and-chemotherapy-for-untreated-unresectable-locally-advancedmetastatic-her2-2026-04-29
FDA Grants Priority Review To BeOne Medicines' Supplemental Biologics License Application For...
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging...
priority reviewbeone medicineslicense applicationfdagrants
https://pages.m1.com/invest/stocks/ONC
BeOne Medicines Ltd. - ONC Stock Price Quote & News - M1
Start with ONC and build your long-term investing strategy with M1. Buy or sell stocks and ETFs commission free.
beone medicinesstock priceltdoncquote
https://www.innovationcity.it/news-biz/6471/lfda-statunitense-concede-la-revisione-prioritaria-a-tevimbra-di-beone-medicines-nel-trattamento-di-prima-linea-delladenocarcinoma-gastroesofageo-her2-positivo.html
L'FDA statunitense concede la revisione prioritaria a TEVIMBRA di BeOne Medicines nel trattamento...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), azienda oncologica globale, oggi ha annunciato che la Food and Drug Administration (FDA)...
beone medicineslfdaconcederevisione
https://indiashorts.com/beone-medicines-announces-first-quarter-2026-financial-results-and-business-updates/285963/
BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates | India Shorts
beone medicinesfirst quarterfinancial resultsbusiness updatesannounces
https://www.businesswirechina.com/en/news/61710.html
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for...
SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announ
beone medicinesfast trackgrantedufda
https://panafricanvisions.com/2025/09/beone-medicines-honored-with-the-global-oncology-innovation-leadership-award-at-biohk-2025-supporting-1-to-accelerate-the-delivery-of-innovative-cancer-therapies/
BeOne Medicines Honored with the Global Oncology Innovation Leadership Award at BIOHK 2025,...
beone medicinesglobal oncologyinnovation leadershiphonoredaward
https://beonemedicines.co.za/
Revolutionizing Cancer Treatment | BeOne Medicines
Mar 2, 2026 - BeOne Medicines is committed to developing innovative medicines against cancer by partnering with the global community to serve patients everywhere.
cancer treatmentbeone medicinesrevolutionizing
https://markets.businessinsider.com/news/stocks/beone-medicines-presents-results-from-studies-of-bg-c9074-bg-68501-at-asco-1034787295
BeOne Medicines presents results from studies of BG-C9074, BG-68501 at ASCO | Markets Insider
BeOne Medicines (ONC) announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology Annual M...
beone medicinesresults frommarkets insiderpresentsstudies
https://de.marketscreener.com/kurs/aktie/BEONE-MEDICINES-AG-26123632/positionen/
BeOne Medicines AG: Fonds mit Positionen | A1437N | US07725L1026 | MarketScreener Deutschland
BeOne Medicines AG: Liste der Fonds und Tracker mit einer grossen laufenden Position in BeOne Medicines AG | A1437N | US07725L1026 | Nasdaq
beone medicinesagfondsmitpositionen
https://www.cmlviz.com/stocks/ONC/holders
ONC Institutional Buying and Selling - Beone Medicines Ltd - Adr Common Stock Institutional Holders...
Get the latest institutional holders transactions for Beone Medicines Ltd - Adr. (ONC). Find out the total of holders shares held, purchased and sold.
buying and sellingbeone medicinescommon stockoncinstitutional
https://pro.medicin.dk/Adresser/Medicinvirksomheder/10817
BeOne Medicines Danmark - Medicin.dk
beone medicinesdanmarkdk
https://www.pharmiweb.com/press-release/2026-05-06/beone-medicines-announces-first-quarter-2026-financial-results-and-business-updates
BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates - PharmiWeb.com
Total global revenues of $1.5 billion for the first quarter, an increase of 35% from the prior yearFoundational BRUKINSA (zanubrutinib) global revenues of $1.1...
beone medicinesfirst quarterfinancial resultsbusiness updatesannounces
https://pressreleasehub.pa.media/article/beone-medicines-announces-first-quarter-2026-financial-results-and-business-updates-72798.html
BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates
beone medicinesfirst quarterfinancial resultsbusiness updatesannounces